Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Mobile-health Network Solutions - Class A Ordinary Shares | MNDR | Aug 30, 2024 | 0.81 | -0.62 |
Mobileye Global A | MBLY | Aug 30, 2024 | 14.28 | +1.71 |
Mobilicom ADR | MOB | Aug 30, 2024 | 0.93 | +5.99 |
Mobix Labs A | MOBX | Aug 30, 2024 | 1.18 | -0.84 |
Moderna | MRNA | Aug 30, 2024 | 77.40 | -0.24 |
Modine Manufacturing | MOD | Aug 30, 2024 | 121.55 | +4.87 |
Modiv | MDV | Aug 30, 2024 | 16.64 | -1.89 |
Modiv Industrial A Pref | MDV-A | Aug 30, 2024 | 24.07 | +1.15 |
ModivCare | MODV | Aug 30, 2024 | 28.86 | +5.99 |
Modular Medical | MODD | Aug 30, 2024 | 1.84 | -0.54 |
Moelis & A | MC | Aug 30, 2024 | 66.79 | +0.21 |
Mogo | MOGO | Aug 30, 2024 | 1.24 | -0.06 |
MOGU ADR A | MOGU | Aug 30, 2024 | 2.04 | -0.87 |
Mohawk Industries | MHK | Aug 30, 2024 | 155.14 | +0.95 |
Molecular Partners ADR | MOLN | Aug 30, 2024 | 5.68 | -12.35 |
Molecular Templates | MTEM | Aug 30, 2024 | 1.53 | +0.66 |
Moleculin Biotech | MBRX | Aug 30, 2024 | 2.55 | +0.39 |
Molina Healthcare | MOH | Aug 30, 2024 | 349.79 | -0.22 |
Molson Coors B | TAP | Aug 30, 2024 | 53.97 | +0.60 |
Molson Coors Beverage Company A | TAP-A | Aug 30, 2024 | 55.78 | +1.40 |
Momentus A | MNTS | Aug 30, 2024 | 0.74 | -9.37 |
Monarch Casino & Resort | MCRI | Aug 30, 2024 | 75.92 | +0.72 |
Monday.com | MNDY | Aug 30, 2024 | 265.89 | +0.74 |
Mondee | MOND | Aug 30, 2024 | 2.00 | +5.26 |
Mondelez International A | MDLZ | Aug 30, 2024 | 71.81 | +1.53 |
Moneyhero | MNY | Aug 30, 2024 | 1.26 | +10.53 |
MoneyLion A | ML | Aug 30, 2024 | 46.42 | +0.54 |
MongoDB A | MDB | Aug 30, 2024 | 290.79 | +18.34 |
Monogram Technologies | MGRM | Aug 30, 2024 | 2.75 | -7.72 |
Monolithic Power Systems | MPWR | Aug 30, 2024 | 934.68 | +0.44 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.